Literature DB >> 1500230

Morphological, immunohistochemical and biochemical characterization of 6 newly established human ovarian carcinoma cell lines.

V Möbus1, C D Gerharz, U Press, R Moll, T Beck, W Mellin, K Pollow, P G Knapstein, R Kreienberg.   

Abstract

Six permanent human tumor cell lines (OV-MZ-1 to 6) were established from 6 patients with serous adenocarcinomas of the ovary. These cell lines were derived from both solid tumors and ascites, from pre-treated and untreated patients, and are available over a range of in vitro passage numbers. The tumor cells grow as monolayers and develop foci of "piled-up' cells in confluent cultures. Flow cytophotometry showed that all the lines exhibited DNA hyperdiploidy with DNA tetraploidy in one cell line and DNA aneuploidy in the other cell lines. The mean population doubling time ranged from 24 to 52 hr. Transmission electron microscopy demonstrated that the tumor cells of all cell lines exhibited features of epithelial differentiation such as desmosomes and intracellular gland-like lumina. Immunocytochemical analysis showed that the co-expression of cytokeratins and vimentin, which is a feature of ovarian serous cystadenocarcinomas in situ, was fully preserved in the majority of cell lines. The main cytokeratin polypeptides expressed were numbers 7, 8, 17, 18 and 19. The tumor-associated antigen CA-125, but not CEA, was shed in the culture supernatant. This was in accordance with FACScan analysis of the cell lines and the level of CA-125 and CEA in the patients' serum. The estrogen and progesterone receptors were negative both in the cell lines and in the original tumors. These new ovarian carcinoma cell lines will be valuable models for further investigations into a variety of biological properties.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500230     DOI: 10.1002/ijc.2910520115

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  31 in total

1.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

2.  Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity.

Authors:  C Zeng; E Kim; S L Warren; S M Berget
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

3.  Tranexamic acid is an active site inhibitor of urokinase plasminogen activator.

Authors:  Guojie Wu; Blake A Mazzitelli; Adam J Quek; Matthew J Veldman; Paul J Conroy; Tom T Caradoc-Davies; Lisa M Ooms; Kellie L Tuck; Jonathan G Schoenecker; James C Whisstock; Ruby H P Law
Journal:  Blood Adv       Date:  2019-03-12

4.  (4-aminomethyl)phenylguanidine derivatives as nonpeptidic highly selective inhibitors of human urokinase.

Authors:  S Sperl; U Jacob; N Arroyo de Prada; J Stürzebecher; O G Wilhelm; W Bode; V Magdolen; R Huber; L Moroder
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

5.  Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.

Authors:  M J Gardner; J B Catterall; L M Jones; G A Turner
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

6.  Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

Authors:  U Reuning; O Wilhelm; T Nishiguchi; L Guerrini; F Blasi; H Graeff; M Schmitt
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

7.  Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion.

Authors:  L M Jones; M J Gardner; J B Catterall; G A Turner
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

8.  New cell lines of gastric and pancreatic cancer: distinct morphology, growth characteristics, expression of epithelial and immunoregulatory antigens.

Authors:  M Heike; O Röhrig; H E Gabbert; R Moll; K H Meyer zum Büschenfelde; W G Dippold; A Knuth
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

9.  Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.

Authors:  Lakmali Munasinghage Silva; Thomas Kryza; Thomas Stoll; Christine Hoogland; Ying Dong; Carson Ryan Stephens; Marcus Lachlan Hastie; Viktor Magdolen; Oded Kleifeld; Jeffrey John Gorman; Judith Ann Clements
Journal:  Mol Cell Proteomics       Date:  2019-01-31       Impact factor: 5.911

10.  Effects of interferon gamma on the proliferation and modulation of cell-surface structures of human ovarian carcinoma cell lines.

Authors:  V J Möbus; W Asphal; P G Knapstein; R Kreienberg
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.